| Chair: Dr Fozia Ahmed | Manchester, UK | |||
|---|---|---|---|---|
| Organisational Issues | ||||
| Implications of national cardiology GIRFT report for CRM - is it realistic or aspirational (or delusional)? | ||||
| Device follow up 2021 - what is frequency of optimal device follow up | Dr John Paisey | Southampton, UK | ||
| Remote monitoring for all - implications and affordability for a bradycardia population | Mr Stuart Allen | Manchester, UK | ||
| Should leadless pacemakers be new standard of care in bradycardia pacing - implications for UK practice: Present and future | Dr Chris Pepper | Leeds, UK | ||
| Chair: Dr Honey Thomas | Northumbria, UK | |||
| Pacing | ||||
| Cardiac pacing - His bundle, septal and LBBB pacing or keep it simple | ||||
| Clinical evidence and Implant challenges | ||||
| Device complications - how to minmise risk | Dr Honey Thomas | Northumbria, UK | ||
| Challenging device cases - Venoplasty tips and tricks | ||||
| MRI and cardiac devices - why is this still an issue? | ||||
| Chair: Dr Guy Haywood | Plymouth, UK | |||
| Miscellaneous | ||||
| ECG - practical tips and tricks for the non specialist | ||||
| Cardiac anatomy for CRM specialist | ||||
| Arrhythmias during pregnancy | Dr Dawn Adamson | Coventry, UK | ||
| Ventriuclar ectopy - when to worry and management options | Dr Lee Graham | Leeds, UK | ||
| Arrhythmias in Athletes: What to Do? | Dr David Begley | Cambridge, UK | ||
| Chair: | ||||
| ICD Therapy | ||||
| Primary prevention ICD therapy - time for a rethink | ||||
| Dilated cardiomyopathy - what is OMT in 2021 | ||||
| LV remodelling - when to decide on device therapy in DCM | Prof Roy Gardner | Glasgow, UK | ||
| Predicting SCD: Beyond EF | Prof Andre Ng | Leicester, UK | ||
| ATP or no ATP for primary prvention ICDs |
| Chair: Prof Dhiraj Gupta, Prof Tim Betts | Liverpool, UK, Oxford, UK | |||
|---|---|---|---|---|
| Pulsed field ablation of AF | Prof Pierre Jais | Bordeaux, FR | ||
| Advances in leadless pacing | Dr Vivek Reddy | New York, US | ||
| COVID-19 and remote monitoring - lessons for the future | Ms Cristiana Monteiro | Oxford, UK | ||
| Cardiac radiotherapy for VT | ||||
| Wearable technology in heart failure | ||||
| Laser ablation | Dr Scott Gall | Blackpool, UK |
| Chair: | ||||
|---|---|---|---|---|
| Ventricular arrhythmia | Dr John Sapp | Halifax, CA | ||
| AF | ||||
| Whats on the horizon – the next 24-26 months |
| Chair: | ||||
|---|---|---|---|---|
| Bradycardia | Prof Kenneth Ellenbogan | Richmond, US | ||
| ICDs / CRT | ||||
| Syncope | Prof Robert Sheldon | Calgary, CA |
| Chair: Prof Richard Schilling | London, UK | |||
|---|---|---|---|---|
| Should we adopt a comprehensive characterisation of AF patients | ||||
| How much can AF be managed by adopting a healthy lifestyle? | ||||
| How do we pick rhythm control for our AF patients? | Prof Paulus Kirchhof | Hamburg, DE | ||
| How much can the AF patient be involved in making management decisions? |
| Chair: Dr Derick Todd, Prof Tim Betts | Liverpool, UK, Oxford, UK | |||
|---|---|---|---|---|
| What QoL reduction related to AF is necessary to make ablation a worthwhile procedure and how do we measure it? | Dr Kim Rajappan | Oxford, UK | ||
| What should we do in addition to PVI for 1st time persistent AF – the posterior box or something else? | Prof Dhiraj Gupta | Liverpool, UK | ||
| How to judge when can we stop anticoagulants in post AF ablation when CHADSVASc>1 | Prof John Camm | London, UK | ||
| Should LAAO isolation & occlusion be part of treatment for persistent AF? | Dr Dhanunjaya Lakkireddy | Kansas, US | ||
| AF ablation to treat heart failure. Therapy or futility? | Prof Pier Lambiase | London, UK | ||
| Do better lesions mean better outcomes? Power, force or electroporation – what is the answer? | Prof Helmut Puererfellner | Linz, AT | ||
| How to define AF substrate: Voltage, velocities or late LGE and does it help guide ablation? | ||||
| How to map atrial fibrillation and identify targets for ablation | Dr Tom Wong | London, UK | ||
| Chair: Dr Shouvik Haldar | London, UK | |||
| AF ablation as first line therapy - Debate (Pro) | Dr Derick Todd | Liverpool, UK | ||
| AF ablation as first line therapy - Debate (Con) | Dr Hugh Calkins | Baltimore, US | ||
| Chair: Prof Andre Ng | Leicester, UK | |||
| Cryo ablation should be the index ablation for all (Pro) | Dr Jason Andrade | Vancouver, CA | ||
| Cryo ablation should be the index ablation for all (Con) | Dr Damian Redfearn | Kingston, CA |
| Chair: Dr Alistair Slade, Prof Derek Connelly | Truro, UK, Glasgow, UK | |||
|---|---|---|---|---|
| Ablate & Pace – the evidence | ||||
| Patient selection – is it only for failed AF ablation and permanent AF? | ||||
| Which CRT patients need AV nodal ablation? And which AV nodal ablation patients need CRT? | ||||
| AV nodal ablation and His bundle pacing – Who, how and why? | Prof Haran Burri | Geneva, CH | ||
| Programming issues – lower rate limit, mode switching, sensor issues |
| Chair: Lord Ajay Kakkar | London, UK | |||
|---|---|---|---|---|
| GLORIA | ||||
| GARFIELD | ||||
| ORBIT | ||||
| PREFER IN AF |
| Chair: Dr Niall Campbell | Manchester, UK | |||
|---|---|---|---|---|
| Post operative AF - Who, how and how to prevent | ||||
| Risk stratification using risk scores - where are we now? |
| Chair: Prof John Camm | London, UK | |||
|---|---|---|---|---|
| 2021 EHRA practical NOAC guide for AF (New edition) | ||||
| AF, dementia and oral anticoagulation | ||||
| AF, diabetes mellitus and oral anticoagulant | ||||
| AF, chronic kidney disease and oral anticoagulants | Prof Reinhold Kreutz | Berlin, DE |
| Chair: Mr Ian Wright | London, UK | |||
|---|---|---|---|---|
| When you don't need an EP study to know the diagnosis | ||||
| The origin of the different pacing manoeuvres we use in EP | ||||
| When its easy to get the diagnosis wrong | ||||
| Focal or re-entrant? Response to entrainment and other clues | Dr Nick Linton | London, UK |
| Chair: | ||||
|---|---|---|---|---|
| Ablation from the aortic root: ATs, VTs and Pathways | ||||
| Protecting the phrenic nerve during ablation | ||||
| Mapping and ablation of papillary muscle VEs | ||||
| High power RF ablation: the way forward? | Prof Andre Ng | Leicester, UK |
| Chair: | ||||
|---|---|---|---|---|
| What's new in the ESC HF2021 guideline: diagnosis | ||||
| What's new in the ESC HF2021 guideline: treatment | ||||
| Atrial fibrillation and HF: do we know what we should do? | ||||
| ICDs for patients with Heart Failure: do we still need them? |
| Chair: Dr Alistair Slade, Dr Ashley Nisbet | Truro, UK, Bristol, UK | |||
|---|---|---|---|---|
| National audit of CRM devices and ablation: key findings from the latest report | ||||
| Patient reported outcomes in Cardiac Rhythm Management – what’s coming? | ||||
| Use of national registry for device surveillance | ||||
| What can NICOR do for your centre? New online tools for you to check your data and benchmark your centre | ||||
| How can our CRM audit data be used by the NHS in the future? Linkage with other sources to improve outcomes? |
| Chair: Prof Aldo Rinaldi | London, UK | |||
|---|---|---|---|---|
| Lessons learned in designing and executing lean, cost-effective trials | ||||
| How to do a meta-analysis and systematic review-The do's and the don'ts | ||||
| What are the top tier journals looking for in an EP/Devices paper? | ||||
| Public-patient involvement in research-How to do it | ||||
| Life as an Arrhythmia Research Nurse- a career worth considering? |